US Trial Shows Gilead’s Remdesivir Drug Works Best in Coronavirus Patients Who Require Extra Oxygen Kumar Jeetendra | May 24, 2020 The US National Institutes of Health (NIH) on Friday said that information from its preliminary of Gilead Sciences Inc’s remdesivir show that the medication offers the most advantage for COVID-19 patients who need additional oxygen yet don’t require mechanical ventilation. The companion investigated information was distributed in the New England Journal of Medicine. The preliminary, …
